Immediate Impact
5 from Science/Nature 70 standout
Citing Papers
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Works of Daniela Vollenweider being referenced
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines
2013
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela Vollenweider | 312 | 361 | 64 | 208 | 16 | 1.0k | |
| Andrew F. Smith | 347 | 160 | 71 | 139 | 31 | 1.4k | |
| Diane Heels‐Ansdell | 181 | 212 | 42 | 229 | 25 | 1.1k | |
| William S. Miles | 161 | 405 | 35 | 221 | 27 | 1.2k | |
| Helen Lee | 68 | 347 | 31 | 135 | 34 | 1.3k | |
| Wally Carlo | 118 | 467 | 889 | 177 | 16 | 1.2k | |
| Thomas Bramley | 95 | 95 | 153 | 150 | 33 | 1.2k | |
| Frank J. Hooper | 164 | 267 | 9 | 71 | 34 | 1.2k | |
| Babu Raja Shrestha | 82 | 283 | 28 | 243 | 17 | 1.3k | |
| Anne M. Damiano | 133 | 47 | 33 | 332 | 12 | 1.0k | |
| David Molloy | 680 | 76 | 202 | 40 | 26 | 1.2k |
All Works
Loading papers...